AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06103630 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Mandibular advancement device
Description: Mandibular advancement device
Study NCT06103630 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device
Description: Mandibular advancement device
Study NCT06230809 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based self-help
Description: Web-based self-help with 5 modules, lasting 5 weeks.
Study NCT05820503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lower abdominis rectus sheath block
Description: Under ultrasound guidance, the probe was transversely placed at the lateral level of the umbilicus . Using the in-plane technique, the needle was advanced until the posterior aspect of the rectus muscle was penetrated. No blood and no gas were drawn back; furthermore, a small volume of saline was initially injected to ensure that the needle tip was correctly positioned. When the needle was located between the posterior rectus muscle and posterior sheath, 5ml of 0.25% ropivacaine was injected bilaterally
Study NCT05820503 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local anesthesia infiltration
Description: Local anesthesia drugs were injected into the peri-umbilicus cord
Study NCT05259267 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Group Therapy for PTG
Description: Online Group Therapy for PTG consists of eight sessions. Each sessions have specific themes. First session: psychoeducation, normalization of the experiences and emotions. Second session: emotion regulation skills. Third session: awareness of the negative thoughts that make patients worried, anxious, feared. Forth session: restructuring of the thoughts and practicing mindfulness technics. 5. session: practicing of self-disclosure skills 6. session: creating a breast cancer story with balancing losses and gains. 7. session: sharing of the effects of breast cancer on life and developing new life priorities 8. session: making life meaning and developing new life goals.
Study NCT05259267 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online Support Group
Description: Online support groups also consist of eight sessions. 1. session: introducing the program and learning the expectancies 2. session: sharing what is known about breast cancer 3. session: risk and protective factors for breast cancer 4. session: sharing side effects of surgical operation and treatments 5. session: sharing the reactions of family, close friends 6. session: patient-doctor relationship and also sharing the challenges and facilitators of healthcare system 7. session: sharing the current position in the treatment and of what has been done for improvement 8. session: sharing the reliable information sources for breast cancer and close
Study NCT06240650 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: modified Health- Dx™ (mHDx) study capsule
Description: The Study mHDx capsule has a mechanism that allows the mHDx to remain resident in the stomach for no more than six (6) hours. After this residency period, the Study mHDx will disassemble and pass safely through the subject's gastrointestinal system.
Study NCT06240650 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: modified Health- Dx™ (mHDx) control capsule
Description: The Control mHDX capsule does not have a functional residency mechanism so it will disassemble once safely through the esophagus (within 10 minutes) and will then pass safely through the subject's gastrointestinal system.
Study NCT05638074 — intervention group
Intervention type: PROCEDURE
Intervention: Interlaminar Epidural Steroid Injection
Description: The patient will be placed in the prone position and cutaneous anesthesia is performed with 3 mL of 2% prilocaine using the sterile technique. After imaging the C7-T1 space with fluoroscopy, it will be entered from the right/left paramedian part of the C7-T1 space with an 18G Touhy needle, and the C-arm will be set in the contralateral oblique position for depth determination.~Under intermittent fluoroscopic imaging, the needle will be advanced, and access to the epidural space wiil be confirmed by the loss of resistance technique. Afterwards, the epidural spread will be controlled with a contrast agent, and a mixture of 10 mg dexamethasone, 1 mL 2% lidocaine hydrochloride, and 1 mL 0.9% saline will be applied to the epidural space. The patient will be discharged with recommendations after being kept under observation for 2 hours post-procedure. All injections will be performed by the same pain medicine specialist who has at least 5 years of experience.
Study NCT04722666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIJ821 Intravenous Injection
Description: MIJ821 supplied in vials to be prepared on a mg/kg basis and to be administered for 40 minutes IV infusion on Day 1, Day 15 and Day 29
Study NCT05689125 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Railroaded bougie
Description: Residents expose the glottis by a video laryngoscope and place the tip of bougie through the vocal cords. Then, an assistant loads an endotracheal tube on the free end of the bougie. Residents advance the endotracheal tube over the bougie and withdraw the bougie.
Study NCT05689125 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Preloaded bougie
Description: Residents expose the glottis by a video laryngoscope and perform the endotracheal intubation using a bougie with a preloaded endotracheal tube while an assistant secures the free end of the bougie. Residents withdraw the bougie when the endotracheal tube reaches an appropriate depth.
Study NCT05689125 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Stylet
Description: Residents expose the glottis by a video laryngoscope and perform the endotracheal intubation with the assistance of a stylet. An assistant withdraws the stylet when the tip of the endotracheal tube passes through the vocal cords. Then residents place the endotracheal tube to an appropriate depth.
Study NCT04722666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo Intravenous Injection
Description: 40 minutes IV infusion of 0.9% sodium chloride solution on Day1, Day 15 and Day 29
Study NCT04722666 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Intravenous Injection
Description: 40 minutes IV infusion of 0.9% sodium chloride solution on Day1, Day 15 and Day 29
Study NCT04618471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Boston Scientific WaveWriter SCS System
Description: WaveWriter SCS Programming
Study NCT05619237 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NanoSALV Catalytic
Description: NanoSALV Catalytic Antimicrobial Wound Dressing Gel is a Health Canada approved medical device for the management of Chronic Wounds.
Study NCT05533840 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ultra-high-resolution computed tomography exams
Description: Participants in the age groups undergo ultra-high-resolution computed tomography exam
Study NCT04863742 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextenza 0.4Mg Ophthalmic Insert
Description: sustained released dexamethasone, 0.4mg
Study NCT04863742 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone Acetate
Description: Prednisolone Acetate 1% QID x 1week, TID x 1week, BID x1 week, QD x1 week.
Study NCT05893459 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Debrief
Description: Post-Stressor Discussion with a Friend
Study NCT04836455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The FDA's The REal Cost vaping prevention ads - Health harms theme
Description: Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about the health harms of vaping will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.
Study NCT04836455 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The FDA's The Real Cost vaping prevention ads - Addiction theme
Description: Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about vaping addiction will be shown to participants at week 0, 1, and 2. Ads will be shown in a random order.
Study NCT04836455 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neutral vaping ads
Description: Three neutral (i.e., purely informational and without graphics) vaping video ads developed by the Investigators will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.
Study NCT04774679 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endosonographic fine needle aspiration biopsy
Description: An endoscopic ultrasound device will be inserted to the stomach and biopsy will performed with a needle
Study NCT05202093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oclean electric toothbrush A
Description: Use Oclean electric toothbrush to brush teeth twice a day for 8 weeks
Study NCT05202093 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oral B manual toothbrush
Description: Use Oral B manual toothbrush to brush teeth twice a day for 8 weeks
Study NCT05202093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oclean electric toothbrush B
Description: Use Oclean electric toothbrush B to brush teeth twice a day for 8 weeks
Study NCT05059548 — intervention group
Intervention type: OTHER
Intervention: Video-Assisted Thoracoscopic Surgery
Description: patients receive Video-Assisted Thoracoscopic Surgery under general anesthesia
Study NCT05265130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YiQiFuMai
Description: YQFM is a redeveloped preparation based on the traditional Chinese medicine formula Sheng-Mai-San, which is widely used in clinical practice in China, mainly for the microcirculatory disturbance-related diseases.
Study NCT05265130 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Normal Saline 250ml
Description: 0.9% Normal Saline 250ml IV, about 40 drops per min.
Study NCT06281145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heart-rate variability biofeedback intervention
Description: Daily deep paced breathing 3-times (minimum 7 minutes each) for 3 months
Study NCT04494789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludrocortisone Acetate
Description: 50mcg
Study NCT04494789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludrocortisone Acetate
Description: 100mcg
Study NCT04494789 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludrocortisone Acetate
Description: 200mcg
Study NCT04494789 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Therapy
Description: NO Fludrocortisone
Study NCT06414538 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Mind Map Technique
Description: Students determined as a result of randomization will be given a pre-test before entering the Family Planning course planned according to the academic calendar. The determined topics will be explained to the students using the digital mind map technique. A post-test will be administered to the students 1 week after the end of the subject and a satisfaction survey of the digital mind map technique will be administered. Permanence test will be applied 35 days after the last test application.
Study NCT06382844 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Detection and quantitation of (blood) tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS).
Description: Specific, sensitive, and reproducible (blood) detection and quantitation of tumor cells in patients with mycosis fungoides (MF) / Sézary syndrome (SS)
Study NCT06414538 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic Method Group
Description: After the students in the control group are determined, a pre-test will be conducted before the subject is given training. The same knowledge test will be repeated as a final test after students have received classical course training and completed the subject. Students will be given a retention exam 35 days after the last exam. After the retention test application, the mind map method will be explained to the students in the control group and the determined topics of the course will be explained with the prepared digital mind map technique. In this way, all students participating in the study will also have access to the additional educational materials used.
Study NCT05639959 — intervention group
Intervention type: DRUG
Intervention: Mometasone Nasal 50 Mcg/Inh Nasal Spray
Description: Mometasone furoate nasal spray effectively reduced total and individual symptoms scores in patients with allergic rhinitis.
Study NCT05639959 — intervention group
Intervention type: DEVICE
Intervention: Nasal spray
Description: device can work properly for actuation during trials
Study NCT05149820 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electronic Point of Care Randomisation tool
Description: Two designs of electronic point of care randomisation tool will be evaluated.
Study NCT05149820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium
Description: Liberal Strategy: magnesium supplementation at serum level \< 0.75 mmol/L Restrictive Strategy: magnesium supplementation at serum level \< 1.0 mmol/L
Study NCT06164158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Procedural Videos
Description: A randomized controlled trial was conducted at Pakistan Institute of Medical Sciences (PIMS) Islamabad between September 1, 2023 to November 30, 2023 under ethical approval from the Institutional ethical review board.
Study NCT06164158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No procedural videos
Description: No procedural videos
Study NCT05185076 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CureSight
Description: watch CureSight treatment for 90 minutes per day, 5 days a week for 16 weeks
Study NCT05185076 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CureSight
Description: watch CureSight treatment for 90 minutes per day, 5 days a week for 16 weeks
Study NCT06129318 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinical Pharmacist Led Pharmaceutical Care
Description: Within the scope of pharmaceutical care, medication review services for past and current medication use were provided by the clinical pharmacist. The patients in the intervention group were given verbal information about the definition of stroke, symptoms, how to manage risk factors, and their medications by the clinical pharmacist on the day of discharge, in addition to the neurologist. Each patient in the intervention group had a scheduled meeting with the clinical pharmacist. During the 1-year follow-up the patient education given by the clinical pharmacist was repeated every 3 months.
Study NCT05000814 — intervention group
Intervention type: DEVICE
Intervention: DLT
Description: VDLT versus the use of DLT with fiberoptic bronchoscope
Study NCT04664855 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trauma-Informed Yoga
Description: 8 weeks of twice weekly trauma-informed yoga for 45 minutes per session
Study NCT05264961 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: voice therapy
Description: sessions of voice therapy
Study NCT05739266 — intervention group
Intervention type: BEHAVIORAL
Intervention: 3 minutes step test
Description: 3 minutes step test- Stair hight:20 cm, Pace: 96 steps per minute
Study NCT05354024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NDV-HXP-S 10μg
Description: NDV-HXP-S 10μg/0.5mL intramuscular (deltoid), 1 dose (booster)
Study NCT05354024 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BNT162b2 30μg
Description: Vaccine against COVID-19 BNT162b2 30μg/0.3mL intramuscular (deltoid), 1 dose (booster)
Study NCT06234618 — intervention group
Intervention type: OTHER
Intervention: visual deprivation
Description: A group of patients walking with eyes open and walking with visual deprivation.
Study NCT06480201 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: Ketamine infusion amount is dictated by BMI, sex, and age.
Study NCT06480201 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Saline infusion amount is dictated by BMI, sex, and age.
Study NCT05047042 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced Cancer Support in Virtual Rehabilitation and Exercise
Description: The study intervention will consist of an individualized 8-week program of online exercise modules, supervised interactive group class and one-to-one consultations with an exercise or rehabilitation specialist and a pain and symptom physician, delivered via secure live Zoom sessions.
Study NCT06463184 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xevinapant
Description: Xevinapant is an investigational medication, taken orally, that promotes cancer cell death via apoptosis.
Study NCT06568419 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transdiagnostic, work-focused Cognitive Behavioural Therapy
Description: Transdiagnostic, work-focused Cognitive Behavioural Therapy focuses on core mechanisms that creates and maintain illness in depression and anxiety. Namely reducing avoidance and/or suppression of unwanted thoughts, avoidance of meaningful activity and increase cognitive flexibility while under psychological stress.
Study NCT04972851 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Determined Learning Model of Instruction (SDLMI)
Description: SDLMI is a teaching model that enables providers to teach students to:~* make choices and decisions about setting a goal~* develop action plans for academic or other goals~* self-monitor and self-evaluate progress toward goal attainment~* adjust the goal or plan
Study NCT04972851 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Determined Learning Model of Instruction (SDLMI)
Description: SDLMI is a teaching model that enables providers to teach students to:~* make choices and decisions about setting a goal~* develop action plans for academic or other goals~* self-monitor and self-evaluate progress toward goal attainment~* adjust the goal or plan
Study NCT05622383 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aromatherapy
Description: aromatherapy,
Study NCT05622383 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music concert
Description: music concert
Study NCT05622383 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aromatherapy and music concert,
Description: aromatherapy and music concert,
Study NCT04559893 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Collaborative Care
Description: Collaborative care consists of a team of providers that includes a care coordinator, a primary care provider (PCP) and a behavioral health consultant (BHC), who provide evidence- and measurement-based care to a panel of patients using a clinical registry. In our model, the CC team also includes a behavioral health psychotherapist (BHP) who consults on a regular basis but does not deliver direct care.
Study NCT06578182 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Colchicine 0.5mg tablets once a day for 3 to 4.5 years
Study NCT06578182 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets once a day for 3 to 4.5 years
Study NCT06117059 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3 fractions of prostate SBRT
Description: Radical radiotherapy using only 3 fractions of prostate SBRT over 3 consecutive days
Study NCT06519565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRG-1801
Description: PRG-1801 is a chimeric antigen receptor T-cell (CAR-T) therapy targeting BCMA. Participants will undergo leukapheresis to collect mononuclear cells for PRG-1801 manufacturing. Prior to infusion, patients receive lymphodepletion with cyclophosphamide (250-300 mg/m2/day) and fludarabine (25-30 mg/m2/day) for 3 days. PRG-1801 is then administered as a single intravenous infusion at one of three dose levels: 35×10\^6, 100×10\^6, or 300×10\^6 CAR-T cells. Premedication with antipyretics and antihistamines is given 30-60 minutes before infusion. The infusion rate is 2-5 ml/min. Patients are monitored for safety and efficacy for up to 24 months post-infusion. Some patients may be eligible for a second infusion if they respond initially but later relapse.
Study NCT06026813 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: test pressure alternating shoes
Description: test pressure alternating shoes
Study NCT05321563 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment)
Description: iDECIDE is a 4 session curriculum that addresses topics such as the neurobiology of substance use, adolescent brain development, industry tactics, motivations for using substances, risk and protective factors, triggers, healthy alternatives, core values, and long-term goal setting. These topics are taught via facilitated discussions, videos, worksheets, and handouts. Facilitators are selected by schools and community agencies to receive free trainings conducted by the iDECIDE team, which includes personnel from the Massachusetts Department of Public Health, Massachusetts General Hospital (MGH) Center for Addiction Medicine, and the Institute for Health and Recovery.
Study NCT06141512 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reduced-exertion high-intensity interval training (REHIT)
Description: Description same as Arm description.
Study NCT06565273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FBL-MTX
Description: Patients will be administered an initial dose of FBL-MTX by subcutaneous route. Subsequent doses will be titrated according to clinical response. Maximum dosage will be 2.5 mg, every 2 weeks.
Study NCT06505226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: in person meditation
Description: in person guided meditation
Study NCT06505226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: in person meditation using headphones
Description: in person meditation using headphones